Ming Yin - China Biologic Sr. Corporate VP and Corporate Secretary
VP
Mr. Ming Yin is Senior Corporationrationrate Vice President of China Biologic Products Inc. He is in charge of investor relations and business development. From March 2008 to May 2012, he held various management positions at our Company with increasing responsibility regarding our financial reporting, finance, investor relations, and business development, including Vice PresidentFinance from August 2010 to March 2012 and assistant to CFO from March 2008 to August 2010. Prior to joining us, Mr. Yin was a tax associate at the New York office of KPMG from February 2007 to February 2008. Prior to that, Mr. Yin held multiple financial management positions in corporations, including accounting manager at Cronimet USA, an international supplier of raw materials for the industrial production of stainless steel Corporation from April 2004 to January 2007 and an accountant at Houston Fruitland Inc. from February 2003 to April 2004. Mr. Yin is a charted financial analyst
| Age | 38 |
| Professional Marks | MBA |
| Phone | (86) 10 6598 3222 |
| Web | www.chinabiologic.com |
China Biologic Management Efficiency
The company has return on total asset (ROA) of 5.82 % which means that it generated a profit of $5.82 on every $100 spent on assets. This is normal as compared to the sector avarege. Similarly, it shows a return on stockholder's equity (ROE) of 9.25 %, meaning that it created $9.25 on every $100 dollars invested by stockholders. China Biologic's management efficiency ratios could be used to measure how well China Biologic manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 7 records | VP Age | ||
| James Swigart | Mesa Air Group | 72 | |
| LL LLM | TFI International | N/A | |
| Jonathan Keyser | Verra Mobility Corp | 41 | |
| Patrick Esq | LB Foster | 54 | |
| Patrick Guinee | LB Foster | 48 | |
| Brigitte Bokemeier | United Airlines Holdings | 47 | |
| David Sauder | LB Foster | 43 | |
Management Performance
| Return On Equity | 9.25 | |||
| Return On Asset | 5.82 |
China Biologic Products Leadership Team
Elected by the shareholders, the China Biologic's board of directors comprises two types of representatives: China Biologic inside directors who are chosen from within the company, and outside directors, selected externally and held independent of China. The board's role is to monitor China Biologic's management team and ensure that shareholders' interests are well served. China Biologic's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, China Biologic's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Min Fang, Director | ||
| Zhijing Liu, Corporate VP | ||
| Ming Yang, CFO | ||
| Joseph Chow, Independent Director | ||
| Gang Yang, Corporate VP and General Manager of Guizhou Taibang | ||
| Xiaosheng Shao, Independent Director | ||
| Ming Yin, Sr. Corporate VP and Corporate Secretary | ||
| Zhijun Tong, Independent Director | ||
| Yungang Lu, Independent Director | ||
| Wenfang Liu, Independent Director | ||
| Wai Yeung, Independent Director | ||
| David Li, Director | ||
| David Gao, Chairman of the Board and Presidentident, CEO | ||
| Xiaoying Gao, Executive Chairman, CEO and Pres |
China Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is China Biologic a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 9.25 | |||
| Return On Asset | 5.82 | |||
| Profit Margin | 29.04 % | |||
| Operating Margin | 37.26 % | |||
| Current Valuation | 3.56 B | |||
| Shares Outstanding | 38.79 M | |||
| Shares Owned By Insiders | 45.08 % | |||
| Shares Owned By Institutions | 51.03 % | |||
| Number Of Shares Shorted | 781.13 K | |||
| Price To Earning | 31.41 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards China Biologic in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, China Biologic's short interest history, or implied volatility extrapolated from China Biologic options trading.
Pair Trading with China Biologic
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if China Biologic position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in China Biologic will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to News Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace News Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back News Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling News Corp A to buy it.
The correlation of News Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as News Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if News Corp A moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for News Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Consideration for investing in China Stock
If you are still planning to invest in China Biologic Products check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the China Biologic's history and understand the potential risks before investing.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |